Dimensional Fund Advisors LP Rigel Pharmaceuticals Inc Transaction History

Dimensional Fund Advisors LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.67 - $3.19 $795,556 - $3.79 Million	-1,187,398 Reduced 80.5%	287,685 $325,000
Q1 2022 May 13, 2022	SELL	$2.22 - $3.45 $573,372 - $891,052	-258,276 Reduced 14.9%	1,475,083 $4.41 Million
Q4 2021 Feb 09, 2022	BUY	$2.36 - $3.57 $168,506 - $254,901	71,401 Added 4.3%	1,733,359 $4.59 Million
Q3 2021 Nov 12, 2021	BUY	$3.5 - $4.5 $3.28 Million - $4.22 Million	937,006 Added 129.25%	1,661,958 $6.03 Million
Q2 2021 Aug 12, 2021	SELL	$3.09 - $4.54 $3.6 Million - $5.28 Million	-1,163,693 Reduced 61.62%	724,952 $3.15 Million
Q1 2021 May 14, 2021	SELL	$3.35 - $4.93 $527,591 - $776,425	-157,490 Reduced 7.7%	1,888,645 $6.46 Million
Q4 2020 Feb 25, 2021	BUY	$2.35 - $3.74 $4.81 Million - $7.65 Million	2,046,135 New	2,046,135 $7.16 Million

334K

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $3.6B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.